Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

The results were compared subsequent to pathology reports ... Sensitivity was 95% for type 2 endometrial cancers (serous carcinoma, clear cell carcinoma, and carcinosarcoma) but fell to 36% ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient (dMMR), surgically resectable endometrial cancer, according to findings presented at the SGO 2025 Annual ...

The most common cancers diagnosed in females are breast, endometrial (the lining ... despite its established role, histopathology faces limitations in early cancer detection, quality variation ...

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer ... of these patients had endometrioid histology, and 15% had unknown mismatch ...

A phase III trial of P-Sam versus physician's choice of chemotherapy is planned that will include patients with B7-H4-positive endometrial cancer whose ... seen in multiple histology types ...